Discontinuation report MIDAZOLAM INJECTION
Report ID | 125902 |
Drug Identification Number | 02423766 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5mL ampoules |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | |
Remaining supply date | |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-10-19 | French | Compare |
v5 | 2020-10-19 | English | Compare |
v4 | 2020-10-08 | French | Compare |
v3 | 2020-10-08 | English | Compare |
v2 | 2020-10-07 | French | Compare |
v1 | 2020-10-07 | English | Compare |
Showing 1 to 6 of 6